Tissue Banking Market is predicted to reach USD 3.42 billion at a CAGR of 8.5% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Tissue Banking Market”.

The tissue banking   market is estimated to register a CAGR of 8.5% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global tissue banking   market Thermo Fisher Scientific Inc. (US), Sigma-Aldrich Co. (US), BioLifeSolutions (US).

Thermo Fisher Scientific Inc. (US), Sigma-Aldrich Co. (US), BioLifeSolutions (US), Lifeline Scientific (US), BioCision, Cesca Therapeutics, Inc. (US),core dynamics GmbH (US), Custom Biogenic Systems (US),Atlanta Biologics Pvt. Ltd. (US), Taylor-Wharton (US), Panasonic Holdings Corporation (Japan), and among others.

Market Highlights

The global tissue banking  market is accounted for to register a CAGR of 8.5% during the forecast period and is estimated to reach USD 3.42 billion by 2032

The single largest growth trend is the increasing prevalence of heart disease. The market space witnesses rising organ donation tendency across the globe which drives the growth of the tissue banking   market. In addition, increasing the collaboration and partnership by the companies. One such key growth factor promoting an exponential increase in Year on Year (%) growth due to the rising awareness about the tissue banking is driving the growth of the tissue banking   market.

Furthermore, incidence of cancer and diabetes propel the growth of tissue banking   market. However, the lack of tissue banks in underdeveloped countries is expected to hamper the growth of the global market. Nevertheless, the rising advancement in drug discovery and development  is projected to create lucrative opportunity pockets for market players. We estimate a more focused business initiates targeting the same would result in greater revenue pockets for market players.

Access full report @ https://www.marketresearchfuture.com/reports/tissue-banking-market-12406

Segment Analysis

The global tissue banking   market is segmented into types, tissue type, and application. Based on the type of segment market is further sub segmented into media and consumable, cryopreservation equipment, thawing equipment, quality control equipment, others. The media and consumable segment were attributed to holding the largest market share in 2022 with a market share of 43.0% of revenue as estimated by MRFR analysts.

The launch of new products in the market. For instance, in May 2022, the major US report of selective fertility preservation outcomes to date found that 70% of women who froze eggs when they were youthful than 38 as well as defrosted at least 20 eggs at a future date.

Further, we estimate that the market segment will have an increasing tendency of organ donation, and rising prevalence of heart disease during the forecast period. It has been identified that the segment market yet witnesses continuous new product development and a growing number of product approvals.  For instance, in June 2022, LifeLink Tissue Bank announced the launch of the Birth Tissue Donation Program, the first of its kind in the Tampa Bay area, in partnership with Tampa General Hospital (TGH).

Further, based on tissue type, the market is segmented into heart valve, cornea, bone, skin, brain & spinal cord, others. based on application channels are further sub segmented into therapeutics, medical research, others.

Regional Analysis

The global tissue banking   market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World.

The tissue banking   market for North America is analyzed across US and Canada. US accounted for a major share of the tissue banking   market in 2022 and is expected to maintain its lead during the forecast period, due to the increasing tendency of egg frozen in the US, availability of advance technology, increasing healthcare infrastructure, developed economic condition boos the growth of tissue banking in the North America region.

Moreover, the Europe market has been persistently growing owing to factors such as the increasing technological development and product innovation, rising research and development activity, increasing occurrence of life threating disease such as heart disease, cancer, and others. Furthermore, increasing numbers of organ donors across the region is driving the growth of tissue banking. Furthermore, the Germany tissue banking market held the largest market share in 2022 and UK tissue banking market is the fastest growing market in the Europe region.

Additionally, market factors, such as an increasing investment by foreign companies, huge chronic disease population, increasing penetration of frozen eggs are driving the growth of tissue banking in the Asia-pacific region.

Furthermore, the rest of the world's market is divided into the Middle East, Africa, and Latin America. The market factors such as growing use of tissue banking, rising awareness about the organ donation for saving other life, growing new technological development and advance medical facility across the region are boost the growth of tissue banking in region.

Key Findings of the Study

• The global tissue banking  market is expected to reach USD 09 billion by 2032, at a CAGR of 8.5% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, due to the the increasing investment by foreign companies, huge chronic disease population, increasing penetration of frozen eggs are driving the growth of tissue banking in the Asia-pacific region.


• Based on type, the media and consumable segment was attributed to holding the largest market in 2022, with an approximate market share of 43.8%.


• Thermo Fisher Scientific Inc. (US), Sigma-Aldrich Co. (US), BioLifeSolutions (US), Lifeline Scientific (US), BioCision, Cesca Therapeutics, Inc. (US), Core Dynamics GmbH (US), Custom Biogenic Systems (US),Atlanta Biologics Pvt. Ltd. (US), Taylor-Wharton (US), Panasonic Holdings Corporation (Japan) and among others